论文部分内容阅读
南京臣功新药研究开发有限公司是致力于新药项目研究开发和转让的高新技术企业,其成立于2001年5月,前身为南京臣功制药有限公司新品部。经过多年的发展,现公司拥有设施完善的现代化实验室和一支阵容强大、专业水平高、实践经验丰富的科研队伍。公司目前已形成以分析、合成、制剂、中药、生物制药并进的多样化发展格局,并逐渐向科、工、贸一体化的高新技术企业迈进。公司研发的项目主要有臣功再欣,臣功再佳和臣功智子。其中臣功再欣是国内第一个上市的儿童感冒药,被列为“医药行业全国十佳品牌”。防治冠心病、心绞痛的臣功再佳是国内第一个获得卫生部批准的单硝酸异山
Nanjing Chen Gong New Drug Research and Development Co., Ltd. is committed to the research and development and transfer of new drug projects in high-tech enterprises, which was established in May 2001, formerly known as Nanjing Shinong Pharmaceutical Co., Ltd. new product department. After years of development, the company now has a well-equipped modern laboratory and a strong lineup, professional standards, practical experience in the research team. At present, the company has formed a diversified development pattern that combines analysis, synthesis, preparation, Chinese medicine and bio-pharmaceuticals and has gradually moved forward to the integration of science, industry and trade in high-tech enterprises. R & D project companies have Chen Gong re-Yan, Chen Gong no matter how good and Chen Gong Zhizi. Which Chen Gong Zaixin is the first listed children's cold medicine, was classified as “Top 10 Brands in the Pharmaceutical Industry ”. Prevention and treatment of coronary heart disease, angina, no matter how good the power is the first approved by the Ministry of Health Monoso-nitric acid